Shirley’s “so well” on her latest treatment – daratumumab
Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.
- Myeloma
- Treatments and side-effects
Shirley Irwin has had radiotherapy and two transplants, had surgery, five different lines of treatment, and relapsed twice.
Kate Vandyke is leading exciting research examining whether a new inhibitor can be used to prepare myeloma patients for therapies and increase their efficacy.
Neda has experienced first-hand the benefit of Leukaemia Foundation support services - all thanks to the generosity of Australians.
Through a Gift in her Will, Davina's been able to fund strategic research projects to help people with blood cancer.
Australian patient outcomes in the rapidly changing fields of genomic testing and precision medicine has been accelerated by Leukaemia Foundation funding.
Kellie and Rita have walked the same path since their diagnoses, but they've had very different experiences.
The Leukaemia Foundation has welcomed news that a new novel combination therapy option will now be available to more myeloma patients through the Pharmaceutical Benefits Scheme (PBS).
Not only do Lynette (Lyn) Healy and Lynnette (Lynnie) Coupar share the same name, but also the tragedy of losing a partner to blood cancer.
Dr Khai Li Chai is working to improve the prevention and treatment of infection in blood cancer patients with antibody replacement therapy.